ClinicalTrials.govpublic full text
A Multi-center Open Label Prospective Study on Early Initiation of Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
iga nephropathy (igan), early initial therapy, nefecon, multi-center, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 919015
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.